PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cannabis reduces blood pressure in older adults, according to Ben-Gurion University researchers

2021-02-08
(Press-News.org) Beer-Sheva, Israel...February 8, 2021 - A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in older adults.

The study, published in the European Journal of Internal Medicine, is the first of its kind to focus on the effect of cannabis on blood pressure, heart rate and metabolic parameters in adults 60 and above with hypertension.

"Older adults are the fastest growing group of medical cannabis users, yet evidence on cardiovascular safety for this population is scarce," says Dr. Ran Abuhasira of the BGU Faculty of Health Sciences, one of Israel's leading medical faculties, and the BGU-Soroka Cannabis Clinical Research Institute. "This study is part of our ongoing effort to provide clinical research on the actual physiological effects of cannabis over time."

Patients were evaluated using 24-hour ambulatory blood pressure monitoring, ECG, blood tests, and body measurements -- both before and three months after initiating cannabis therapy.

In the study, researchers found a significant reduction in 24-hour systolic and diastolic blood pressure values, with the lowest point occurring three hours after ingesting cannabis either orally via oil extracts or by smoking. Patients showed reductions in blood pressure in both daytime and nighttime, with more significant changes at night.

The BGU researchers theorize that the relief from pain, the indication for prescription cannabis in most patients, may also have contributed to a reduction in blood pressure.

"Cannabis research is in its early stages and BGU is at the forefront of evaluating clinical use based on scientific studies," says Doug Seserman, chief executive officer of American Associates, Ben-Gurion University of the Negev. "This new study is one of several that has been published recently by BGU on the medicinal benefits of cannabis."

INFORMATION:

Additional researchers who participated in the study include: Prof. Victor Novack, director of the BGU-Soroka Cannabis Clinical Research Institute and BGU-Soroka Clinical Research Center and Research Authority; Prof. Yosef Haviv, director of the Department of Nephrology at Soroka; Prof. Merav Leiba, Prof. Adi Leiba and Dr. Larisa Ryvo of the Assuta Ashdod Academic Medical Center.

About American Associates, Ben-Gurion University of the Negev American Associates, Ben-Gurion University of the Negev (AABGU) plays a vital role in sustaining David Ben-Gurion's vision: creating a world-class institution of education and research in the Israeli desert, nurturing the Negev community and sharing the University's expertise locally and around the globe. Activities include showcasing BGU's academic excellence and cutting-edge research through educational programs, events and informative communications. AABGU's main purpose is to support Ben-Gurion's vision and the university that bears his name by creating a community of Americans committed to improving the world tomorrow from the heart of the Israeli desert today. For more information visit http://www.aabgu.org.



ELSE PRESS RELEASES FROM THIS DATE:

Happy childhood? That's no guarantee for good mental health

Happy childhood? Thats no guarantee for good mental health
2021-02-07
It's well understood that a difficult childhood can increase the likelihood of mental illness, but according to new research from the University of South Australia, a happy and secure childhood does not always protect a child from developing a mental illness later in life. Conducted in partnership with the University of Canberra, the finding is part of a study published in Current Psychology, which examined how early childhood experiences relate to different developmental pathways, and how these might be associated with poor mental health. Given that both positive and negative childhood experiences were found to manifest as anxiety or other mental health disorders into adulthood, ...

Shuffling bubbles reveal how liquid foams evolve

Shuffling bubbles reveal how liquid foams evolve
2021-02-06
Tokyo, Japan - Researchers from Tokyo Metropolitan University studied the dynamics of foams. When a drop of water was added to a foam raft, the bubbles rearranged themselves to reach a new stable state. The team found that bubble movement was qualitatively different depending on the range of bubble sizes present. Along with analogies with soft-jammed materials, these findings may inspire the design of new foam materials for industry. Foams are everywhere. Whether it's soaps and detergents, meringues, beer foam, cosmetics or insulation for clothing and building, we're surrounded by everyday ...

COVID-19: Schools urgently need guidelines on improving ventilation in classrooms

2021-02-06
There is an urgent need for guidelines on how schools can use ventilation to reduce the risk of COVID-19 transmission in the classroom, according to doctors at Imperial College London and the headteacher of a secondary school in Pinner, Middlesex. In a commentary published by the Journal of the Royal Society of Medicine, the authors say that improving air quality in classroom spaces should be as important as following government advice regarding social distancing, mask-wearing and hand washing. The authors point to lessons from the airline industry, where the risk of contracting COVID-19 on a flight ...

Drug 'breakthrough' gives longest-ever survival in nonresectable liver cancer patients

Drug breakthrough gives longest-ever survival in nonresectable liver cancer patients
2021-02-06
6 February: The IMbrave150 trial found median overall survival was 19.2 months in patients treated with atezo+bev vs 13.4 months for those treated with sorafenib alone, the current standard treatment (HR, 0.66 [95% CI, 0.52-0.85]; P=0.0009). Survival at 18 months was 52% with atezo+bev and 40% in patients treated with sorafenib. All patients in the trial had nonresectable HCC - the most common form of liver cancer - and had not previously been treated with systemic therapy. A total of 501 patients were treated in the multicentre, open label, randomised controlled trial and the new follow-up figures confirm the superiority of the atezo+bev combination over sorafenib in this group of patients with HCC. Atezolizumab is an immune ...

The Lancet Public Health: Survey taken after France's first COVID-19 wave indicates almost one-third of working-age people could reject a vaccine

2021-02-06
Around one in three working-age adults (29%) surveyed in France in July 2020 would refuse any COVID-19 vaccine. Willingness to receive a COVID-19 vaccination depended upon its country of origin, effectiveness, rate of serious side effects, and site of vaccination. Although attitudes may have changed since July 2020 with the approval of several vaccines and a second wave of COVID-19, the findings suggest that communicating the collective benefits of herd immunity reduced people's hesitancy about being vaccinated. Nearly one in three working-age adults in France (29%) surveyed in July 2020 - when lockdown restrictions had been ...

Peginterferon-lambda shows strong antiviral action to accelerate clearance of COVID-19

2021-02-06
TORONTO (February 5, 2021) - A clinical study led by Dr. Jordan Feld, a liver specialist at Toronto Centre for Liver Disease, University Health Network (UHN), showed an experimental antiviral drug can significantly speed up recovery for COVID-19 outpatients - patients who do not need to be hospitalized. This could become an important intervention to treat infected patients and help curb community spread, while COVID-19 vaccines are rolled out this year. "This treatment has large therapeutic potential, especially at this moment as we see aggressive variants of the virus spreading around the globe which are less sensitive to both vaccines and treatment ...

Critical flaw found in lab models of the human blood-brain barrier

2021-02-05
NEW YORK, NY (Feb. 5, 2020)--Cells used to study the human blood brain barrier in the lab aren't what they seem, throwing nearly a decade's worth of research into question, a new study from scientists at Columbia University Vagelos College of Physicians and Surgeons and Weill Cornell Medicine suggests. The team also discovered a possible way to correct the error, raising hopes of creating a more accurate model of the human blood-brain barrier for studying certain neurological diseases and developing drugs that can cross it. The study was published online Feb. ...

Physical discipline and cognitive deprivation associated with specific types of developmental delay

2021-02-05
Washington, DC, February 5, 2021 - A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that in a diverse, cross-national sample of youth, physical discipline and cognitive deprivation had distinct associations with specific domains of developmental delay. The findings are based on the Multiple Indicator Cluster Surveys, which is an ongoing, international household survey initiative coordinated and assisted by the United Nations agency, UNICEF. "Physical discipline and cognitive deprivation are well-established risks to child development. However, it is rare that these experiences are examined in relation to each other," said lead author ...

Tom Hanks' COVID-19 diagnosis likely shaped behaviors, thoughts toward virus

2021-02-05
UNIVERSITY PARK, Pa.-- When actor Tom Hanks announced his COVID-19 diagnosis on March 11, 2020, many Americans were still learning about the virus and its severity. According to new research, Hanks' announcement may have affected how some people understood the virus and their behavior toward its prevention. The day after Hanks posted the news on social media, Jessica Gall Myrick, an associate professor in the Donald P. Bellisario College of Communications at Penn State, and Jessica Fitts Willoughby, associate professor at Washington State University, surveyed 682 people about their attitudes and behaviors toward COVID-19. Just under 90% of the people surveyed had heard about Hanks' social ...

Center for BrainHealth researchers create virtual reality cognitive assessment

2021-02-05
Virtual reality isn't just for gaming. Researchers can use virtual reality, or VR, to assess participants' attention, memory and problem-solving abilities in real world settings. By using VR technology to examine how folks complete daily tasks, like making a grocery list, researchers can better help clinical populations that struggle with executive functioning to manage their everyday lives. Lead author Zhengsi Chang is a PhD student that works in the lab of Daniel Krawczyk, PhD, deputy director of the Center for BrainHealth®. Along with Brandon Pires, a researcher at Texas Tech University Health Sciences Center, the team investigated whether VR can be used to effectively test ...

LAST 30 PRESS RELEASES:

Viking colonizers of Iceland and nearby Faroe Islands had very different origins, study finds

One in 20 people in Canada skip doses, don’t fill prescriptions because of cost

Wildlife monitoring technologies used to intimidate and spy on women, study finds

Around 450,000 children disadvantaged by lack of school support for color blindness

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

[Press-News.org] Cannabis reduces blood pressure in older adults, according to Ben-Gurion University researchers